Avian pancreatic polypeptide (APP) inhibits atropine resistant vasodilation in cat submandibular salivary gland and nasal mucosa: possible interaction with VIP.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004351:Drug Resistance; D004558:Electric Stimulation; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D009297:Nasal Mucosa / Q000098:blood supply* / Q000187:drug effects; D010191:Pancreatic Polypeptide / Q000494:pharmacology*; D010275:Parasympathetic Nervous System / Q000502:physiology*; D012039:Regional Blood Flow / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D013363:Submandibular Gland / Q000098:blood supply* / Q000187:drug effects / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects*
D005768:Gastrointestinal Hormones; D014660:Vasoactive Intestinal Peptide; D010191:Pancreatic Polypeptide; D001285:Atropine